Table 3 Accruing Clinical Trials Combining Targeted Therapy with radiation Therapy
Agent | Institute |
|---|---|
Sunitinib | MD Anderson Cancer Center |
SU5416 | University of Chicago |
Bevacizumab | 1) Benaroya Research Institute 2) Virginia Mason |
RAD001 | Shelba Medical Center |